Consumer

Nightfood (OTC: NGTF) Hires MSourceIdeas and Industry Expert Lionel Binnie to Develop Distribution Footprint in College Campus and Hospitality Markets

Tarrytown, NY, Oct 29, 2019 Nightfood, Inc. (otcqb:NGTF), the start-up ice cream company addressing America’s $50 billion-dollar nighttime snacking problem, has engaged Lionel Binnie, founder of MSourceIdeas, to grow Nightfood distribution and partnerships in non-traditional […]

Newsmakers

NexTech (OTC: NEXCF) To Launch New 3D-AR-360 Ad Network

NEW YORK and TORONTO, Oct. 24, 2019 (GLOBE NEWSWIRE) — NexTech AR Solutions (the “Company” or “NexTech”) (otcqb:NEXCF) (NTAR)(N29), the industry leader in augmented reality, is pleased to announce that it is preparing to launch a 3D-AR-360 […]

Newsmakers

NexTech (OTC: NEXCF) Launches New AR Analytics Dashboard To Track AR Product Interactions Conversions and Engagement

NEW YORK and TORONTO, Oct 17, 2019  — NexTech AR Solutions (the “Company” or “NexTech”) (otcqb:NEXCF) (NTAR)(N29) NexTech AR Solutions, the industry leader in augmented reality, is pleased to announce the release of a seamless […]

Newsmakers

Hoth Therapeutics (NASDAQ: HOTH) to Present at the Dawson James 5th Annual Small Cap Growth Conference

NEW YORK, Oct. 15, 2019 — Hoth Therapeutics, Inc. (NASDAQ: HOTH) a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis–also known as eczema–as well as dermatological and chronic wound […]

Newsmakers

Hoth Therapeutics (NASDAQ: HOTH) Makes Donation to National Eczema Association in Sponsorship of “National Eczema Awareness Month”

NEW YORK, Oct. 14, 2019  — Hoth Therapeutics, Inc.(NASDAQ: HOTH)  a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis–also known as eczema–as well as dermatological and chronic wound […]

Healthcare

CytoDyn (OTC: CYDY) Announces FDA Clearance to Proceed with Phase 2 Clinical Trial of Leronlimab (PRO 140) for Treatment of NASH

VANCOUVER, Washington, Oct. 01, 2019– CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today FDA clearance […]

Newsmakers

Medicine Man Technologies (OTC: MDCL) Resoundingly Applauds the Historical Passing of the SAFE Banking Act by the U.S. House of Representatives

– SAFE Banking Act would provide cannabis companies access to banking services that all other legal businesses have- American cannabis companies would be on more equal footing with Canadian cannabis peers with access to depository […]